InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,221.42
(
0.00%
)
US TECH 100
17,703.20
(
-0.11%
)
Dow Jones
39,431.51
(
0.00%
)
Brent Oil
82.38
(
-1.00%
)
Bitcoin
61,619.59
(
-2.04%
)
Post# of 158400
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

The PoPo

Send PM Follow Ignore
Followers 54
Posts 1023
Boards Moderated 0
Alias Born 03/15/2013

The PoPo

Re: None

Friday, 08/22/2014 10:05:51 AM

Friday, August 22, 2014 10:05:51 AM

Post# of 158400
"Breast cancer – Benitec has granted a license to Regen Biopharma for the development of a ddRNAibased therapy called dCellVax. Regen recently announced the successful silencing of the IDO gene in dendritic cells, an approach that in animal models has demonstrated the ability to induce regression of breast cancer."

- From Benitec's Preliminary 2014 Year-End Report

It's nice to see Benitec is keeping tabs on the most recent news from Regen BioPharma.

http://member.afraccess.com/media?id=CMN://2A813285&filename=20140822/BLT_01545441.pdf
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up